Home
|
Search
|
Browse
|
Index
|
Login
The Medical Letter
Treatment Guidelines
May 13, 2013 (Issue 1416)
Canagliflozin (Invokana) for Type 2 Diabetes
Canagliflozin (kan" a gli floe' zin;
Invokana
– Janssen), a sodium-glucose co-transporter 2...
Pasireotide (Signifor) for Cushing's Disease
The FDA has approved the somatostatin analog pasireotide diaspartate (
Signifor
– Novartis)...
Alogliptin (Nesina) for Type 2 Diabetes
Omalizumab (Xolair) for Chronic Urticaria
Ospemifene (Osphena) for Dyspareunia
Fulltext Search for: